期刊文献+

胱抑素C在肾脏疾病中的临床应用 被引量:7

Clinical application of cystatin C in kidney disease
下载PDF
导出
摘要 目的探讨肾功能损害时血清胱抑素C(Cystatin C,CysC)作为早期敏感标志物对临床诊断的价值。方法采用胶乳增强透射比浊法测定血清CysC的浓度,同时测定血肌酐。结果血清CysC在健康对照组、肾储备下降组、肾功能不全组、肾功能衰竭组、尿毒症组的值分别为(0.76±0.14)、(1.95±0.61)、(2.78±0.86)、(6.23±1.68)、(7.93±1.25)mg/L,随着肾功能的损害程度增加,血清CysC的浓度升高,相邻各组之间CysC差异均有统计学意义(P<0.01)。肾功能正常组血清CysC值与健康对照组相比差异有统计学意义(P<0.05),而两组血清肌酐值相比差异无统计学意义(P>0.05)。结论血清CysC作为反映肾脏损伤的敏感指标,可以替代内生肌酐清除率来判断肾小球滤过率,因此有更广阔的应用前景。 Objective To discuss the diagnostic value of using serum Cystatin C(CysC) as an early sensitive mark in kidney functional impairment.Methods The latex enhanced immunoturbidimetric method was adopted to test the concentration of serum CysC,and serum creatinine(Scr) was simultaneously detected.Results The value of serum CysC in control group,kidney function reserve descent group,kidney insufficiency group,kidney failure group and uremia group were(0.76±0.14) mg/L,(1.95±0.61) mg/L,(2.78±0.86) mg/L,(6.23±1.68) mg/L and(7.93±1.25) mg/L respectively.With the increase of kidney function impairment,serum CysC concentration was elevated.The difference of serum CysC among adjacent groups had statistical significance(P〈0.05).The value of CysC in normal kidney function group was statistically different from that in the normal control group,while the Scr values had no statistical difference(P〉0.05).Conclusion Serum cystatin C is a sensitive mark to reflect the kidney impairment,which could be used to judge the glomerular filtration function instead of the endogenous creatinine clearance(Ccr).Using cystatin C to evaluate the abnormal glomerular filtration rate(GFR) has a wide prospect.
作者 周燕 黄湘宁
出处 《检验医学与临床》 CAS 2011年第6期684-685,共2页 Laboratory Medicine and Clinic
关键词 胱抑素C 肾功能损害 肾小球滤过率 cystatin C kidney functional impained glomerular filtration rate
  • 相关文献

参考文献7

  • 1李玉艳,杨振坤,李强.胱抑素C在临床中的应用进展[J].国际检验医学杂志,2006,27(9):812-813. 被引量:106
  • 2府伟灵,黄君富.肾脏疾病标志物的研究概况[J].国外医学(临床生物化学与检验学分册),2004,25(2):97-98. 被引量:80
  • 3Keevil GB, Kilpatrick ES, Nichols SP, et al. Niological variation of cystatin C: implication for the assessment of glomerular filtration rate [J]. Clin Chem, 1998,44 (7) : 1535-1539.
  • 4张磊,宫健,胡昭.肾小球滤过功能的敏感指标血清γ-球蛋白血清胱抑素C[J].临床荟萃,2003,18(12):715-717. 被引量:51
  • 5Aksun SA, Ozmen D, Ozmen B, et al. Beta 2 microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy[J]. Exp Clin Endoerinol Diabetes, 2004,112 (4) :195-200.
  • 6Mojiminiyi OA, Abdella N. Evaluation of cystatin C and beta-2 mieroglobulin as markers of renal function in patients with type 2 deabetes mellitus[J]. J Diabetes Complications,2003,17(3) : 160-168.
  • 7Jovanovie D,Krstivojevic P,Obradovic I,el al. Serum cystatin C and beta 2 microglobulin as markers of glomerular filtration rate[J]. Ren Fail,2003,25(1):123-1,33.

二级参考文献17

  • 1Zore I, Krasovec M, Cimerman N, et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem, 2001, 382(5): 805-810.
  • 2Takeuchi M, Fukuda Y, Nakano I, et al. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol, 2001, 13(8): 951-955.
  • 3Domej W, Tilz GP, Foldes-Papp Z, et al. Cystatin C of pleural effusion as a novel diagnostic aid in pleural diseases of different aetiologies. Clin Sci (Lond), 2002, 102 (3) :373-380.
  • 4Mannes AJ, Martin BM, Yang HY, et al. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain,2003, 102(3): 251-256.
  • 5Eisenach JC, Thomas JA, Rauck RL, et al. Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans. Pain, 2004, 107(3): 207-212.
  • 6Gupta-Malhotra M, Levine DM, Cooper RS, et al. Decreased levels of cystatin C, an inhibitor of the elastolytic enzyme cysteine protease, in acute and subacute phases of kawasaki disease. Cardiology, 2003, 99(3): 121-125.
  • 7Gokkusu CA, Ozden TA, Gul H, et al. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem, 2004, 37(2) : 94-97.
  • 8Orlando R, Mussap M, Plebani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosi.s. Clin Chem, 2002, 48(6 Pt 1): 850-858.
  • 9Perlemoine C, Beauvieux MC, Rigalleau V, et al. Interest of cystatin C in screening diabetic patients for early impairment of renal function. Metabolism, 2003, 52(10): 1258-1264.
  • 10Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal,2004, 18(1): 31-35.

共引文献227

同被引文献73

  • 1曾凯宏,于晓,逯心敏.Cystatin C在诊断肾功能损害中的应用及其新进展[J].第四军医大学学报,2005,26(17):1623-1625. 被引量:11
  • 2蔡钢强,垢敬,焦连亭.胱抑素C的生物学特性及临床应用评价[J].国际检验医学杂志,2006,27(5):457-460. 被引量:57
  • 3韩振武,赵然,邵树茂,韩迎春.血清胱抑素C用以评估肾小球滤过率的价值[J].中国误诊学杂志,2007,7(18):4222-4223. 被引量:69
  • 4Grubb A,Simonsen O,Sturfel T G,et al.Serum concentration of cystain C,factor D and B2-mincroglobulin as a measure of glomerular filtration rate[J].Acta Med Scand,1985,218(5):499-502.
  • 5Coll E,Botey A,Alvarez L,et al.Serum Cystain C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J].Am J Kindney Dis,2000,36(1):29-34.
  • 6Aksun SA,Ozmen D,Ozmen B,et al.Beta 2 microglobulin and cysta-tin C in type 2 diabetes:assessment of diabetic nephropathy[J].ExpClin Endocrinol Diabetes,2004,112(4):195-200.
  • 7Sortwell CE, Pappas GD, Sagen J, et al. Chromaffin cell xenografts in the rat neocortex can produce antidepressive activity in the forced swimming test. Exp Brain Res 1995; 103:59 -69
  • 8Freed WH, Dymecki J, Poltorack M, et al. Intraventricular brain allografts and xenografts: studies of survival and rejection with and without systemic sensitization. Prog Brain Res 1988; 78:233 -41
  • 9Ortega JD, Sagen J, Pappas GO, et al. Short-term immunosuppression enhances long-term survival of bovine chromaffin cell xenografts in rat CNS. Cell Transplantat 1992; 1:33 -41
  • 10Sagen J, Wang H, Tresco P, et al. Transplants of immunologically isolated xenogeneic chromaffin cells provide a long-term source of pain-reducing neuroactive substances. J Neurosci 1993; 13: 2415- 23

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部